ZA973514B - New chiral phenyldihydrofuranones. - Google Patents
New chiral phenyldihydrofuranones.Info
- Publication number
- ZA973514B ZA973514B ZA9703514A ZA973514A ZA973514B ZA 973514 B ZA973514 B ZA 973514B ZA 9703514 A ZA9703514 A ZA 9703514A ZA 973514 A ZA973514 A ZA 973514A ZA 973514 B ZA973514 B ZA 973514B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- phenyldihydrofuranones
- new chiral
- sec
- date
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19617864A DE19617864A1 (de) | 1996-04-23 | 1996-04-23 | Neue chirale Phenyldihydrofuranone |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA973514B true ZA973514B (en) | 1997-11-18 |
Family
ID=7793287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9703514A ZA973514B (en) | 1996-04-23 | 1997-04-23 | New chiral phenyldihydrofuranones. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6011060A (xx) |
EP (1) | EP0900212B1 (xx) |
JP (1) | JP2000510105A (xx) |
AT (1) | ATE256673T1 (xx) |
AU (1) | AU2949497A (xx) |
DE (2) | DE19617864A1 (xx) |
DK (1) | DK0900212T3 (xx) |
ES (1) | ES2213214T3 (xx) |
PT (1) | PT900212E (xx) |
WO (1) | WO1997040032A1 (xx) |
ZA (1) | ZA973514B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19617864A1 (de) * | 1996-04-23 | 1997-10-30 | Schering Ag | Neue chirale Phenyldihydrofuranone |
JP4510383B2 (ja) * | 2001-05-23 | 2010-07-21 | 田辺三菱製薬株式会社 | 軟骨疾患修復治療用組成物 |
KR20040007596A (ko) | 2001-05-23 | 2004-01-24 | 다나베 세이야꾸 가부시키가이샤 | 골절 치료 촉진용 조성물 |
TWI221838B (en) * | 2001-08-09 | 2004-10-11 | Tanabe Seiyaku Co | Pyrazinoisoquinoline compound or naphthalene compound |
US6962940B2 (en) * | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
CA2481385A1 (en) * | 2002-04-12 | 2003-10-23 | Celgene Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
EP1496878A4 (en) * | 2002-04-12 | 2007-12-26 | Celgene Corp | TECHNIQUES FOR IDENTIFYING ANGIOGENESIS MODULATORS, COMPOUNDS DISCOVERED BY THESE TECHNIQUES AND TREATMENT TECHNIQUES USING THESE COMPOUNDS |
US7776893B2 (en) * | 2003-09-05 | 2010-08-17 | Nycomed Gmbh | Use of PDE4 inhibitors for the treatment of diabetes mellitus |
US8017633B2 (en) | 2005-03-08 | 2011-09-13 | Nycomed Gmbh | Roflumilast for the treatment of diabetes mellitus |
CA2637373A1 (en) * | 2006-01-25 | 2007-08-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2745320A1 (de) * | 1977-10-05 | 1979-04-19 | Schering Ag | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung ii |
DE2655369A1 (de) * | 1976-12-03 | 1978-06-08 | Schering Ag | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung |
WO1987006576A1 (en) * | 1986-04-29 | 1987-11-05 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
KR930703262A (ko) * | 1990-11-06 | 1993-11-29 | 스튜어트 알. 슈터 | 이미다졸리디논 화합물 |
DK0660711T3 (da) * | 1992-09-14 | 1999-10-18 | Forssmann Wolf Georg Prof Dr | Hidtil ukendt anvendelse af phosphodiesterase IV-inhibitorer |
DE19617864A1 (de) * | 1996-04-23 | 1997-10-30 | Schering Ag | Neue chirale Phenyldihydrofuranone |
-
1996
- 1996-04-23 DE DE19617864A patent/DE19617864A1/de not_active Withdrawn
-
1997
- 1997-04-22 AU AU29494/97A patent/AU2949497A/en not_active Abandoned
- 1997-04-22 DK DK97923757T patent/DK0900212T3/da active
- 1997-04-22 EP EP97923757A patent/EP0900212B1/de not_active Expired - Lifetime
- 1997-04-22 ES ES97923757T patent/ES2213214T3/es not_active Expired - Lifetime
- 1997-04-22 DE DE59711138T patent/DE59711138D1/de not_active Expired - Fee Related
- 1997-04-22 US US09/171,632 patent/US6011060A/en not_active Expired - Fee Related
- 1997-04-22 JP JP09537603A patent/JP2000510105A/ja not_active Withdrawn
- 1997-04-22 WO PCT/DE1997/000826 patent/WO1997040032A1/de active IP Right Grant
- 1997-04-22 PT PT97923757T patent/PT900212E/pt unknown
- 1997-04-22 AT AT97923757T patent/ATE256673T1/de not_active IP Right Cessation
- 1997-04-23 ZA ZA9703514A patent/ZA973514B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO1997040032A1 (de) | 1997-10-30 |
ES2213214T3 (es) | 2004-08-16 |
EP0900212A1 (de) | 1999-03-10 |
PT900212E (pt) | 2004-05-31 |
DK0900212T3 (da) | 2004-04-19 |
US6011060A (en) | 2000-01-04 |
DE59711138D1 (en) | 2004-01-29 |
DE19617864A1 (de) | 1997-10-30 |
AU2949497A (en) | 1997-11-12 |
JP2000510105A (ja) | 2000-08-08 |
EP0900212B1 (de) | 2003-12-17 |
ATE256673T1 (de) | 2004-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA987491B (en) | Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation | |
ZA975335B (en) | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors. | |
HK1015269A1 (en) | Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof | |
AU4308397A (en) | Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors | |
HUP0101625A3 (en) | New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same | |
TNSN97010A1 (fr) | Cyclopentanopyridyl-oxazolidinones contenant des heteroatomes. | |
GB9423970D0 (en) | Oxidation | |
WO2001078702A3 (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
AU2401697A (en) | 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors | |
CA2406057A1 (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
DE60001735D1 (de) | 1-aminotriazolo 4,3-a chinazolin-5-one und/oder -thione inhibitoren von phosphodiesterasen iv | |
HK1019404A1 (en) | Injection formulations of avermectins or milbemycins based on castor oil, their preparation, and use of castor for preparing the same | |
ZA973514B (en) | New chiral phenyldihydrofuranones. | |
HK1040077A1 (en) | Substituted-3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases | |
ZA978089B (en) | 3,4-diaryloxazolone derivatives, their methods of preparation, and their use in therapeutics. | |
HK1048318A1 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors. | |
ZA989664B (en) | 3-substituted tetrahydropyrimidinone derivatives, their preparation and use. | |
MX9700244A (es) | Utilizacion de un poliholosido en una composicion limpiadora o desmaquillante, y composicion que lo incluye. | |
AU4707101A (en) | Method and system for online third party referral system customized to the purchaser's needs | |
ZA9810625B (en) | Benzylidenepyrazolones, their preparation and use. | |
ZA989571B (en) | 2-Substituted 1,2-Benzoisonthiazole derivatives, their preparation and use. | |
ZA992192B (en) | Humectant and lubricant solution for ophthalmic use. | |
ZA966577B (en) | Pharmaceutical composition. | |
ZA97902B (en) | Biologically active ureido derivatives useful in the treatment of multiple sclerosis. | |
AU6107999A (en) | 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |